Scientific Testing Accelerator Transition (STAT) supports Rhode Island researchers and early-stage life sciences companies with testing and validation studies to advance technologies toward commercialization.
Funder: Rhode Island Life Science Hub
Due Dates: Not announced
Funding Amounts: Up to $50,000 per grant
Summary: STAT supports testing and validation studies that help Rhode Island researchers and early-stage life sciences companies advance technologies toward commercialization.
Key Information: Projects should establish a clear pathway toward commercialization, company formation, or future funding.
Scientific Testing Accelerator Transition (STAT) is a Rhode Island Life Science Hub program supporting the testing and validation needed to move promising life sciences technologies toward commercialization. It helps Rhode Island researchers and early-stage companies generate critical data to evaluate a technology’s potential and reach its next development milestone.
Part of the Hub’s Innovation and Scientific Discovery offerings, STAT funds defined studies, including laboratory testing, preclinical research, and work performed by contract research organizations. Its focus is on producing evidence that informs the next steps in technology development, with a clear pathway toward commercialization, company formation, or future funding.